Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elhadji Malick Thiam
Observed names:
E. Magny Thiam,
E.M. Thiam
Institution:
Centre Hospitalier Universitaire Amiens-Picardie
Observed institutions:
Université de Yaoundé I,
Centre Hospitalier Universitaire Amiens-Picardie,
University Teaching Hospital of Yaounde
ORCID:
0009-0009-0390-093X
Observed ORCID:
0009-0009-0390-093X
OpenAlex ID:
A5069351912
Real‐World Outcomes of Atezolizumab–Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort
2025
·
Manon Allaire
, Elhadji Malick Thiam
, et al.
·
Liver International
·
12
Hypertension artérielle sévère nouvellement diagnostiquée dans un pays en Afrique sub-saharienne : aspects épidemio-cliniques, thérapeutique et évolutifs
2019
·
C. Ngongang Ouankou
, L.O. Chendjou Kapi
, et al.
·
Annales de Cardiologie et d Angéiologie
·
10
Second-line practices in the era of immunotherapy in HCC: The CHIEF cohort
2026
·
Marie Decraecker
, Héloïse Bourien
, et al.
·
JHEP Reports
·
1
PDF
1487P Extended follow-up at 42 months of atezolizumab–bevacizumab in advanced HCC: Insights from the CHIEF prospective study
2025
·
M. Allaire
, E.M. Thiam
, et al.
·
Annals of Oncology
·
1
153P Evolution of second-line practices in the era of immunotherapy: Real-life data from the French prospective CHIEF cohort
2025
·
M. Decraecker
, J. Edeline
, et al.
·
Annals of Oncology
·
1
PDF
Show more works
View as search
Works count:
5
Citation count:
25
H-index:
2
I10-index:
2
Year
Topic
Type